Evidence map›Paper›PMID 20414690›Full record

ArticleArchives of virology2010

Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART.

Carlos A Lopez, Manuel Vazquez, Martin D Hill, Maria Del C Colon, Tirtsa Porrata-Doria, Ian C D Johnston, Eric Lorenzo

Open access · hybridAbstract read
In one paragraph

Article in Archives of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Impact of Depression and Inflammation on the Progression of HIV Disease.Journal of clinical & cellular immunology · 2016
    Article
  6. Article
  7. Review
  8. Envelope gene evolution and HIV-1 neuropathogenesis.Journal of neuroinfectious diseases · 2015
    Article
  9. Article
  10. Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Review
  11. Article
  12. Review
  13. Article
  14. Hematopoietic stem/precursor cells as HIV reservoirs.Current opinion in HIV and AIDS · 2011
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Carlos A LopezMolecular Virology Laboratory, Department of Physiology and Pharmacology, Ponce School of Medicine, Ponce, PR 00732, USA.
Manuel Vazquez
Martin D Hill
Maria Del C Colon
Tirtsa Porrata-Doria
Ian C D Johnston
Eric Lorenzo
Ponce Health Sciences University · PRMiltenyi Biotec (Germany) · DENational Institutes of Health · US

Funding

VIRAL SEQUENCES IN PEDIATRIC HIV INFECTION IN PRG12RR003050 · NCRR · PONCE SCHOOL OF MEDICINE · PI ARMSTRONG, RAUL A · 1985 to 2011
$28.1M
Therapeutic Immunization in Monkey Model of AIDSS06GM008239 · NIGMS · PONCE SCHOOL OF MEDICINE · PI MATTA, JAIME L · 1989 to 2009
$21.5M
NCRR NIH HHS 2G12 RR 003050-20NCRR NIH HHS G12 RR003050NIGMS NIH HHS S06 GM008239NIGMS NIH HHS S06-GM 008239
6 · The paper itself

Abstract

An assay to characterize plasma human immunodeficiency virus 1 (HIV-1) sequences for patients with low viral loads was developed by combining the selective binding of anti-CD44 MicroBeads with a nested RT-PCR targeting the env C2V4 region. Sequences were obtained from 10 of 20 HIV+ patients who had viral loads below 48 copies/ml. Sequences derived from plasma were compared to those from CD14+ CD16 +monocytes and CD4+ T cells. The plasma sequences were most closely related to those amplified from monocytes, suggesting that during successful antiretroviral therapy, the predominant plasma virus originates from myeloid cells. By characterizing HIV-1 RNA sequences from 8 ml of plasma while avoiding multiple steps, which can lead to contamination and deterioration, this method can help elucidate the viral forms in patients with therapeutically suppressed HIV-1. Understanding the source of residual viremia is crucial in developing approaches for viral eradication.

Indexed as

Antiretroviral Therapy, Highly ActiveRNA, ViralAdultAgedCD4-Positive T-LymphocytesEvolution, MolecularFemaleHIV-1HIV InfectionsHumansLipopolysaccharide ReceptorsMaleMiddle AgedMonocytesPhylogenyPlasmaLipopolysaccharide ReceptorsReceptors, IgGRNA, Viral

Identifiers

PMID20414690
PMCPMC2880236
OpenAlexW2025960989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.